Skip to main content

Johnson & Johnson ownership: holders and insider trading

  • JNJ · NYSE
  • Healthcare
  • Pharmaceuticals
  • S&P 500
$285.75+0.79%Close 13 Nov 2026 · Market value $684.4B

As filed, its directors and officers own 0.2% of the shares (proxy statement, 11 Mar 2026); 4,673 institutional managers reported holding 74.8% at 30 Jun 2026. Over the last twelve months, insiders bought $257.7K and sold $150.7M of shares on the open market.

From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.

Largest holders

HolderTypeSharesOf the companySourceAs of
The Vanguard GroupHolder247M10.25%*Form 13F30 Jun 2026
BlackRock, Inc.Holder212M8.81%*Form 13F30 Jun 2026
Vanguard Capital ManagementHolder181M7.49%Schedule 13G31 Mar 2026
State Street CorporationHolder134M5.56%*Form 13F30 Jun 2026
Geode Capital ManagementInstitution59.1M2.45%*Form 13F30 Jun 2026
JPMorgan ChaseInstitution58.3M2.42%*Form 13F30 Jun 2026
Morgan StanleyInstitution44.8M1.86%*Form 13F30 Jun 2026
Norges BankInstitution31.8M1.32%*Form 13F30 Jun 2026
State Farm Mutual Automobile Insurance CoInstitution31.6M1.31%*Form 13F30 Jun 2026
UBSInstitution29.5M1.22%*Form 13F30 Jun 2026
Northern TrustInstitution28.8M1.20%*Form 13F30 Jun 2026
Capital GroupInstitution25.4M1.06%*Form 13F30 Jun 2026
Bank of AmericaInstitution23.4M0.97%*Form 13F30 Jun 2026
T. Rowe PriceInstitution23.0M0.96%*Form 13F30 Jun 2026
Fidelity (FMR)Institution22.6M0.94%*Form 13F30 Jun 2026
Wellington ManagementInstitution22.6M0.94%*Form 13F30 Jun 2026
BNYInstitution21.7M0.90%*Form 13F30 Jun 2026
Goldman SachsInstitution19.7M0.82%*Form 13F30 Jun 2026
Legal & GeneralInstitution19.3M0.80%*Form 13F30 Jun 2026
Charles SchwabInstitution19.1M0.80%*Form 13F30 Jun 2026

Insider transactions latest 25

InsiderDateTransactionSharesPriceValue
Schmid Timothy · EVP, WW Chair, MedTech2 Sep 2026Open-market sale−22.5K$274.74$6.19M
Schmid Timothy · EVP, WW Chair, MedTech2 Sep 2026Open-market sale−11.1K$274.74$3.04M
Schmid Timothy · EVP, WW Chair, MedTech2 Sep 2026Option exercise+11.1K$131.94$1.46M
Schmid Timothy · EVP, WW Chair, MedTech2 Sep 2026Option exercise+22.5K$151.41$3.41M
Taubert Jennifer L · EVP, WWC. Innovative Medicine17 Aug 2026Open-market sale−15.0K$263.36$3.95M
Taubert Jennifer L · EVP, WWC. Innovative Medicine17 Aug 2026Option exercise+15.0K$115.67$1.74M
Duato Joaquin · CEO and Chairman of the Board · Director13 Aug 2026Open-market sale−21.0K$262.00$5.50M
Duato Joaquin · CEO and Chairman of the Board · Director13 Aug 2026Option exercise+123K$115.67$14.26M
Duato Joaquin · CEO and Chairman of the Board · Director13 Aug 2026Open-market sale−102K$261.00$26.70M
Forminard Elizabeth · EVP, Chief Legal Officer6 Aug 2026Open-market sale−6.6K$255.93$1.68M
Forminard Elizabeth · EVP, Chief Legal Officer6 Aug 2026Option exercise+9.3K$131.94$1.23M
Forminard Elizabeth · EVP, Chief Legal Officer6 Aug 2026Open-market sale−9.3K$257.76$2.41M
Duato Joaquin · CEO and Chairman of the Board · Director5 Aug 2026Open-market sale−42.0K$258.06$10.83M
Duato Joaquin · CEO and Chairman of the Board · Director5 Aug 2026Open-market sale−6.5K$258.74$1.69M
Broadhurst Vanessa · EVP, Global Corp Affairs20 Jul 2026Option exercise+11.1K$129.51$1.44M
Broadhurst Vanessa · EVP, Global Corp Affairs20 Jul 2026Option exercise+11.9K$131.94$1.57M
Broadhurst Vanessa · EVP, Global Corp Affairs20 Jul 2026Open-market sale−23.1K$251.27$5.79M
Wengel Kathryn E · EVP, Chief TO and Risk Officer11 Jun 2026Open-market sale−10.0K$241.15$2.41M
Wengel Kathryn E · EVP, Chief TO and Risk Officer11 Jun 2026Option exercise+10.0K$115.67$1.16M
REED JOHN C · EVP, Innovative Medicine, R&D1 May 2026Shares withheld for tax−11.0K$229.85$2.53M
REED JOHN C · EVP, Innovative Medicine, R&D1 May 2026Option exercise+25.3K——
Decker Robert J · VP Corporate Controller27 Feb 2026Open-market sale−4.1K$247.87$1.01M
Decker Robert J · VP Corporate Controller27 Feb 2026Option exercise+4.1K$115.67$471.4K
Schmid Timothy · EVP, WW Chair, MedTech20 Feb 2026Open-market sale−1.3K$245.66$324.8K
Schmid Timothy · EVP, WW Chair, MedTech18 Feb 2026Open-market sale−9.0K$244.53$2.20M

Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.

JNJ in the terminal

Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.